NCT03228394 - A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

May 10, 2019

Study Completion Date

May 10, 2020

Conditions

DepressionDepressive DisorderDepression, PostpartumBehavioral SymptomsMood DisordersMental DisordersPuerperal DisordersPregnancy ComplicationsPostpartumPPD

Interventions

DRUG

Ganaxolone

Ganaxolone IV

DRUG

Placebo

Placebo IV

Trial Locations (16)

10032

Marinus Research Site, New York

23298

Marinus Research Site, Richmond

30030

Marinus Research Site, Decatur

30331

Marinus Research Site, Atlanta

32216

Marinus Research Site, Jacksonville

45417

Marinus Research Site, Dayton

66206

Marinus Research Site, Leawood

66211

Marinus Research Site, Overland Park

72211

Marinus Research Site, Little Rock

75062

Marinus Research Site, Irving

77058

Marinus Research Site, Houston

84058

Marinus Research Site, Orem

84124

Marinus Research Site, Salt Lake City

91945

Marinus Research Site, Lemon Grove

92103

Marinus Research Site, San Diego

92626

Marinus Research Site, Costa Mesa